ClassID:

21256

A61K45/06 - page 28 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  -  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Recent Application in this class:
#8101
20230190858
2023-06-22

Treatment for Diseases Caused By RNA Viruses

#8102
20230190844
2023-06-22

COMPOSITION AND METHOD FOR TREATING CANCER WITH CANNABINOIDS

#8103
20230190843
2023-06-22

METHODS FOR ENHANCING SLEEP QUALITY

#8104
20230190834
2023-06-22

IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES

#8105
20230190828
2023-06-22

AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE

#8106
20230190825
2023-06-22

METHODS AND COMPOSITIONS FOR REDUCING CLOSTRIDIUM DIFFICILE INFECTION

#8107
20230190824
2023-06-22

BACTERIUM OF THE CHRISTENSENELLACEAE FAMILY IN THE PREVENTION AND/OR TREATMENT OF HYPERTRIGLYCERIDEMIA

#8108
20230190821
2023-06-22

REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS, METHODS OF PRODUCTION, AND METHODS OF USE THEREOF

#8109
20230190797
2023-06-22

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY

#8110
20230190782
2023-06-22

Nucleoside derivatives and methods of use thereof

#8111
20230190774
2023-06-22

METHOD OF USING SUBSTRATES OF AKR1Bl/AKR1B10 AS ANTI-CANCER DRUGS

#8112
20230190773
2023-06-22

INHIBITION OF SLC TRANSPORTER ACTIVITY OR EXPRESSION TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY

#8113
20230190768
2023-06-22

COMBINATION COMPRISING TRICYCLE COMPOUND AND USE THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING HBV

#8114
20230190767
2023-06-22

COMPOSITIONS AND METHODS FOR ENHANCING WNT SIGNALING FOR TREATING CANCER

#8115
20230190752
2023-06-22

COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME

#8116
20230190749
2023-06-22

TREATMENT OF BRAIN CANCER

#8117
20230190744
2023-06-22

PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A PROGRAMMED DEATH-LIGAND 1 (PD-L1) INHIBITOR AND METHODS OF USE THEREOF

#8118
20230190740
2023-06-22

AN NK-1 RECEPTOR ANTAGONIST FOR TREATING A DISEASE SELECTING FROM SEPSIS, SEPTIC SHOCK, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) OR MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)

#8119
20230190736
2023-06-22

SMALL MOLECULE THERAPEUTICS FOR THE TREATMENT OF VIRAL INFECTIONS

#8120
20230190734
2023-06-22

LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF CORONAVIRUS DISEASE AND SYMPTOMS THEREOF

#8121
20230190730
2023-06-22

4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT

#8122
20230190727
2023-06-22

METHOD OF TREATMENT OF SCHIZOPHRENIA

#8123
20230190724
2023-06-22

METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH PRIDOPIDINE

#8124
20230190719
2023-06-22

TOPICAL FORMULATIONS OF (1S)-1-PHENYL-2-PYRIDIN-2-YLETHANAMINE

#8125
20230190718
2023-06-22

METHODS FOR THE TREATMENT OF PANCREATITIS AND PREVENTION OF PANCREATIC CANCER

#8126
20230190717
2023-06-22

P38 GAMMA INHIBITORS AND METHOD OF USE THEREOF

#8127
20230190714
2023-06-22

PRIMARY METHODS AND PROCESSES FOR LIFE EXTENSION IN MODERN-DAY HUMANS

#8128
20230190708
2023-06-22

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION

#8129
20230190707
2023-06-22

COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY

#8130
20230190694
2023-06-22

COMPOSITIONS FOR AND METHODS OF PRECISION CANCER TREATMENT

#8131
20230190693
2023-06-22

STABLE DIGLYCERIDE EMULSIONS AND METHODS FOR TREATING ORGAN INJURY

#8132
20230190684
2023-06-22

METHODS OF TREATING COVID-19 WITH A NICLOSAMIDE COMPOUND

#8133
20230190683
2023-06-22

METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS

#8134
20230190674
2023-06-22

Methods for Reduction of Body Weight with Subcutaneous Formulations

#8135
20230190663
2023-06-22

PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF

#8136
20230190662
2023-06-22

Efficacy of a Gastro-Retentive Bile Acid Sequestrant Dosage Form

#8137
20230190656
2023-06-22

COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION

#8138
20230190653
2023-06-22

METHOD FOR REDUCING OFF-TARGET UPTAKE OR ACCUMULATION OF AGENTS

#8139
20230190651
2023-06-22

Topical Aerosol Foams

#8140
20230184777
2023-06-15

DIAGNOSIS AND TREATMENT OF CANCER

#8141
20230184774
2023-06-15

DIAGNOSIS AND TREATMENT OF CANCERS SHOWING HIGH EXPRESSION OF PIWI AND/OR NMD COMPLEX PROTEIN

#8142
20230184771
2023-06-15

METHODS FOR TREATING BLADDER CANCER

#8143
20230183367
2023-06-15

PHARMACEUTICAL COMPOSITIONS OF HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF

#8144
20230183350
2023-06-15

Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS

#8145
20230183336
2023-06-15

ANTIBODIES THAT BIND TO LRP5 PROTEINS AND METHODS OF USE

#8146
20230183330
2023-06-15

FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING

#8147
20230183323
2023-06-15

METHODS FOR PREVENTING, REVERSING OR TREATING A COVID-19 INFECTION

#8148
20230183321
2023-06-15

RCOM PROTEIN BASED CARBON MONOXIDE SCAVENGERS AND PREPARATIONS FOR THE TREATMENT OF CARBON MONOXIDE POISONING

#8149
20230183319
2023-06-15

VARIANT ACTRIIB PROTEINS AND USES THEREOF

#8150
20230183265
2023-06-15

Crystal Form of Macrocyclic Tyrosine Kinase Inhibitor and Preparation Method therefor

#8151
20230183261
2023-06-15

Macrocyclic MCL-1 Inhibitors and Methods of Use

#8152
20230183253
2023-06-15

NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY

#8153
20230183249
2023-06-15

NEW TRIAZINOINDOLE COMPOUNDS

#8154
20230183240
2023-06-15

Inhibitors of cyclin-dependent kinases

#8155
20230183238
2023-06-15

RING DEUTERATED GABOXADOL AND ITS USE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS

#8156
20230183232
2023-06-15

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

#8157
20230183228
2023-06-15

SUBSTITUTED PYRAZOLYL COMPOUNDS AND METHODS OF USE THEREOF

#8158
20230183203
2023-06-15

ANTIBACTERIAL COMPOUNDS

#8159
20230183197
2023-06-15

INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT

#8160
20230183195
2023-06-15

COCRYSTALS OF (1R,3S)-3-(5-CYANO-4-PHENYL-1,3-THIAZOL-2-YLCARBAMOYL)CYCLOPENTANE CARBOXYLIC ACID

#8161
20230183172
2023-06-15

Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

#8162
20230183166
2023-06-15

Methods for making and using endoxifen

#8163
20230183067
2023-06-15

Sodium thiosulfate-containing pharmaceutical compositions

#8164
20230181763
2023-06-15

APPLICATION OF AAV44.9 VECTOR IN GENE THERAPY FOR THE INNER EAR

#8165
20230181756
2023-06-15

CCR7 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER

#8166
20230181739
2023-06-15

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

#8167
20230181733
2023-06-15

COMPOSITIONS AND METHODS FOR STEM CELL TRANSPLANT CONDITIONING AND USES THEREOF

#8168
20230181731
2023-06-15

Anti-TIGIT Antibodies

#8169
20230181698
2023-06-15

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

#8170
20230181680
2023-06-15

PREVENTION AND TREATMENT OF ORGAN INJURIES

#8171
20230181678
2023-06-15

NOVEL ANTIBACTERIAL PEPTIDE OR PEPTIDE ANALOG AND USE THEREOF

#8172
20230181675
2023-06-15

NOVEL FORMUATIONS

#8173
20230181669
2023-06-15

SKIN SENSITIZER DELIVERY SYSTEM

#8174
20230181648
2023-06-15

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF A PERFUSION DISORDER

#8175
20230181645
2023-06-15

METHOD TO IMPROVE CANCER VACCINES

#8176
20230181634
2023-06-15

Chimeric antigen receptors targeting FLT3

#8177
20230181631
2023-06-15

MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA

#8178
20230181622
2023-06-15

Enhancement of vaccine efficacy and antibiotic efficacy

#8179
20230181604
2023-06-15

Use of Mitochondria-Targeted Antioxidants to Treat Severe Inflammatory Conditions

#8180
20230181602
2023-06-15

TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

#8181
20230181601
2023-06-15

TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

#8182
20230181600
2023-06-15

INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES

#8183
20230181599
2023-06-15

PROGESTOGEN FORMULATIONS AND USES THEREOF

#8184
20230181598
2023-06-15

FORMULATIONS AND METHODS OF TREATING COVID-19 AND PREVENTING INFECTION WITH SARS-CoV-2

#8185
20230181589
2023-06-15

PRMT5 INHIBITORS FOR OCULAR THERAPY

#8186
20230181582
2023-06-15

COMPOSITIONS AND METHODS FOR TREATING LUNG INJURIES ASSOCIATED WITH VIRAL INFECTIONS

#8187
20230181576
2023-06-15

Organic compounds

#8188
20230181575
2023-06-15

Antiproliferative compounds and bispecific antibody against BCMA and CD3 for combined use

#8189
20230181573
2023-06-15

Diketopiperazine Microparticles with Defined Specific Surface Areas

#8190
20230181571
2023-06-15

USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION

#8191
20230181565
2023-06-15

CRENOLANIB COMBINATION THERAPY

#8192
20230181560
2023-06-15

COMPOUND FOR PREVENTING OR TREATING A VIRAL INFECTION

#8193
20230181559
2023-06-15

Methods of Using C-Met Modulators

#8194
20230181556
2023-06-15

USE OF PSYCHOTROPIC DRUGS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS

#8195
20230181554
2023-06-15

AGENT FOR PROTECTING AND/OR REGENERATING NEUROMUSCULAR JUNCTION

#8196
20230181544
2023-06-15

DOSING REGIMENS FOR USE IN TREATING RELAPSED AND REFRACTORY MULTIPLE MYELOMA WITH VENETOCLAX

#8197
20230181543
2023-06-15

TREATMENT OF CARM1-OVEREXPRESSING AND/OR ARID1A MUTANT CANCERS WITH IRE-1/XBP-1 INHIBITORS

#8198
20230181534
2023-06-15

USE OF A PROTEASOME INHIBITOR FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS

#8199
20230181529
2023-06-15

PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA

#8200
20230181527
2023-06-15

APICAL SODIUM-DEPENDENT TRANSPORTER INHIBITOR COMPOSITIONS

#8201
20230181523
2023-06-15

Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections

#8202
20230181521
2023-06-15

ISOTOPICALLY ENRICHED ANALOGS OF 5,6-METHYLENEDIOXY-2-AMINOINDANE (MDAI)

#8203
20230181520
2023-06-15

USE OF HYDROPEROXY ALCOHOLS AND THE DERIVATIVES THEREOF AS ANTIMICROBIAL AGENTS

#8204
20230181518
2023-06-15

Prevention of rosacea inflammation

#8205
20230181504
2023-06-15

Combination therapy to treat urea cycle disorders

#8206
20230181499
2023-06-15

Hydroxyureamethyl-Acylfulvene for Treating Brain Cancer or CNS Cancer

#8207
20230181490
2023-06-15

PRO-LYCOPENE RICH COMPOSITION AND METHODS OF USING SAME

#8208
20230181489
2023-06-15

COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY

#8209
20230181487
2023-06-15

COMPOSITIONS IN SUPPORT OF HEALTH AND MENTAL ACCUITY

#8210
20230181484
2023-06-15

Uses and Formulations of Cannabinoids

#8211
20230181475
2023-06-15

COMPOSITION COMPRISING METHYLFOLATE

#8212
20230181459
2023-06-15

TREATMENT OF OPHTHALMOLOGICAL CONDITIONS WITH ACETYLCHOLINESTERASE INHIBITORS

#8213
20230175069
2023-06-08

COMPOSITIONS AND METHODS FOR DETECTING GENE FUSIONS OF ESR1 AND CCDC170 FOR DETERMINING INCREASED RESISTANCE TO ENDOCRINE THERAPY AND FOR CANCER TREATMENT

#8214
20230174980
2023-06-08

CHANNEL MODULATORS

#8215
20230174975
2023-06-08

SYSTEMS AND METHODS FOR VIRAL GENOME TARGETING

#8216
20230174954
2023-06-08

BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION

#8217
20230174933
2023-06-08

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

#8218
20230174671
2023-06-08

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS

#8219
20230174666
2023-06-08

ANTI-CD26 PROTEINS AND USES THEREOF

#8220
20230174665
2023-06-08

Monoclonal Antibodies and Antigen Binding Fragments Thereof for Suppressing CD73 Immune Checkpoint and Uses Thereof

#8221
20230174662
2023-06-08

METHODS OF TREATING CASTRATE-RESISTANT PROSTATE CANCER

#8222
20230174659
2023-06-08

AGONISTIC TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES

#8223
20230174656
2023-06-08

TOCILIZUMAB AND REMDESIVIR COMBINATION THERAPY FOR COVID-19 PNEUMONIA

#8224
20230174647
2023-06-08

Antibodies Binding to ILT4

#8225
20230174633
2023-06-08

METHODS AND COMPOSITIONS FOR MODULATING LIPID STORAGE IN ADIPOSE TISSUE

#8226
20230174631
2023-06-08

ANTI-C5 ANTIBODIES AND USES THEREOF

#8227
20230174613
2023-06-08

METHODS AND COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM

#8228
20230174601
2023-06-08

HDM-2 TARGETING COMPOSITIONS CAUSE TUMOR CELL NECROSIS RATHER THAN APOPTOSIS OF CANCER CELLS

#8229
20230174600
2023-06-08

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

#8230
20230174562
2023-06-08

RADIO-AND CHEMO-PROTECTIVE COMPOUNDS

#8231
20230174549
2023-06-08

SALT AND CRYSTAL FORMS OF 4-AMINO-5-(6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZO[D]IMIDAZOL-2-YL)THIENO[2,3-B]PYRIDIN-6(7H)-ONE

#8232
20230174539
2023-06-08

Substituted Pyrrolo[2,3-D]Pyrimidines As Inhibitors Of Protein Arginine Methyl Transferase 5 (PRMT5)

#8233
20230174534
2023-06-08

Compounds useful in HIV therapy

#8234
20230174529
2023-06-08

CRYSTALLINE FORMS AND FORMULATIONS OF A VCP/p97 INHIBITOR

#8235
20230174522
2023-06-08

Benzisoxazole Sulfonamide Derivatives

#8236
20230174518
2023-06-08

KRAS G12D PROTEIN INHIBITORS

#8237
20230174513
2023-06-08

AMIDE COMPOUNDS AND USES THEREOF

#8238
20230174512
2023-06-08

CDK inhibitors

#8239
20230174503
2023-06-08

NEW ANTI-MALARIAL AGENTS

#8240
20230174491
2023-06-08

Deuterated compounds and uses thereof

#8241
20230173110
2023-06-08

NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER

#8242
20230173108
2023-06-08

COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE

#8243
20230173103
2023-06-08

COMPOSITIONS AND METHODS FOR TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA AND ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL

#8244
20230173077
2023-06-08

FATTY ACYL AND FATTY ETHER CONJUGATES OF REMDESIVIR AND ITS ACTIVE METABOLITES AS ANTIVIRALS

#8245
20230173072
2023-06-08

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

#8246
20230173067
2023-06-08

METHODS OF TREATING HER2 POSITIVE CANCER WITH TUCATINIB IN COMBINATION WITH TRASTUZUMAB AND AN OXALIPLATIN-BASED CHEMOTHERAPY

#8247
20230173049
2023-06-08

FUSION PROTEINS AND METHODS OF USE THEREOF

#8248
20230173046
2023-06-08

MULTICOMPONENT CHEMICAL COMPOSITION OF A PEPTIDE-BASED NEOANTIGEN VACCINE

#8249
20230173039
2023-06-08

METHOD AND DRUG FOR TREATING ALZHEIMER DISEASE

#8250
20230173034
2023-06-08

ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE

#8251
20230173021
2023-06-08

IL-18 Binding Protein (IL-18BP) In Respiratory Diseases

#8252
20230172998
2023-06-08

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE INTRANASAL SYSTEM

#8253
20230172993
2023-06-08

COMPOSITIONS AND METHODS FOR TRANSPLANTATION OF COLON MICROBIOTA

#8254
20230172977
2023-06-08

THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME

#8255
20230172968
2023-06-08

CONTROLLED RELEASE HYALURONIC ACID COMPOSITIONS

#8256
20230172967
2023-06-08

BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT

#8257
20230172966
2023-06-08

COMPOSITION FOR THE PREVENTION AND TREATMENT OF FOLATE AND/OR VITAMIN B12 DEFICIENCY CONDITIONS, PARTICULARLY HYPERHOMOCYSTEINEMIA

#8258
20230172965
2023-06-08

TARGETING LTBP3 FOR NONALCOHOLIC STEATOHEPATITIS (NASH)-INDUCED LIVER FIBROSIS

#8259
20230172964
2023-06-08

Nucleoporins as drug targets for anti-proliferative therapeutics

#8260
20230172962
2023-06-08

NRTIS, NRTI METABOLITES, AND NRTI ANALOGS FOR MACULAR DEGENERATION AND VIRAL INFECTIONS

#8261
20230172961
2023-06-08

THERAPEUTICS FOR COVID-19

#8262
20230172956
2023-06-08

Combinatorial therapy for use in inducing immunogenic cell death in cancer cells

#8263
20230172925
2023-06-08

SKIN-CARE COMPOSITIONS AND USES THEREOF

#8264
20230172919
2023-06-08

AN INSULIN SENSITIZER FOR USE IN THE PREVENTION AND/OR TREATMENT OF THE DAMAGES CAUSED BY RETINAL DETACHMENT

#8265
20230172913
2023-06-08

COMPOUNDS FOR USE IN THE REACTIVATION OF HIV IN LATENT HIV-INFECTED CELLS

#8266
20230172911
2023-06-08

METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE

#8267
20230172910
2023-06-08

Antibody drug conjugates comprising sting agonists

#8268
20230172907
2023-06-08

SARS-COV-2 INHIBITORS

#8269
20230172903
2023-06-08

INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE

#8270
20230172895
2023-06-08

METHODS OF TREATING OR PREVENTING ORGANOPHOSPHORUS POISONING

#8271
20230172891
2023-06-08

PREVENTION AND TREATMENT OF EFFECTS OF AGING AND AGE-ASSOCIATED DISORDERS WITH KETONE SUPPLEMENTATION

#8272
20230172885
2023-06-08

THIOL-CONTAINING COMPOUNDS FOR USE IN TREATING CORONAVIRUS

#8273
20230172881
2023-06-08

Multidrug pain management package

#8274
20230172872
2023-06-08

Use of an RXR agonist and taxanes in treating Her2+ cancers

#8275
20230172855
2023-06-08

METHOD OF LYOPHILIZING LIPOSOMES

#8276
20230172850
2023-06-08

DRUG DELIVERY SYSTEM WITH ENHANCED IMMUNE ACTIVE FUNCTION

#8277
20230172841
2023-06-08

Vasoconstriction compositions and methods of use

#8278
20230172199
2023-06-08

Antimicrobial Compositions and Related Methods of Use

#8279
20230167503
2023-06-01

METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES

#8280
20230167427
2023-06-01

STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA

#8281
20230167401
2023-06-01

BACTERIUM OF THE CHRISTENSENELLACEAE FAMILY FOR THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY DISEASES AND/OR INFLAMMATORY GASTROINTESTINAL DISEASES AND/OR CANCERS

#8282
20230167195
2023-06-01

Hexokinase 2-specific inhibitors for use in acute central nervous system injury

#8283
20230167186
2023-06-01

METHODS OF ADMINISTERING ANTI-OX40 ANTIBODIES

#8284
20230167171
2023-06-01

METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST

#8285
20230167168
2023-06-01

High affinity antibodies targeting tau phosphorylated at serine 413

#8286
20230167143
2023-06-01

Prodrugs of L-BHDU and methods of treating viral infections

#8287
20230167142
2023-06-01

METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATES

#8288
20230167126
2023-06-01

Compositions and methods for treating atopic dermatitis

#8289
20230167125
2023-06-01

Compositions and methods for treating atopic dermatitis

#8290
20230167119
2023-06-01

DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE COMPOUNDS AS ADENOSINE 2A RECEPTOR AND ADENOSINE 2B RECEPTOR ANTAGONIST

#8291
20230167116
2023-06-01

PURINE DERIVATIVES AS SIK-3 INHIBITORS

#8292
20230167106
2023-06-01

SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE

#8293
20230167100
2023-06-01

QUINOLINE COMPOUNDS AND COMPOSITIONS FOR INHIBITING EZH2

#8294
20230167076
2023-06-01

1,2,4-oxadiazole derivatives as immunomodulators

#8295
20230167064
2023-06-01

TREATMENTS OF INFLAMMATORY BOWEL DISEASE

#8296
20230167057
2023-06-01

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#8297
20230165959
2023-06-01

Dosing Strategy that Mitigates Cytokine Release Syndrome for Therapeutic Antibodies

#8298
20230165931
2023-06-01

A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS

#8299
20230165930
2023-06-01

CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS

#8300
20230165929
2023-06-01

TREATMENT OF RESPIRATORY TRACT DISEASES AND INFECTIONS WITH ASCORBIC ACID COMPOSITIONS

#8301
20230165928
2023-06-01

COMPOSITIONS AND METHODS COMPRISING STABLE REDUCED GLUTATHIONE

#8302
20230165924
2023-06-01

Herbal Formulation for the Prevention and Management of COVID-19 by Regulating Immunomodulatory Properties

#8303
20230165918
2023-06-01

REDUCTION OF CYTOKINE STORM AND PATHOLOGICAL INFLAMMATION INCLUDING CAUSED BY CORONAVIRUS USING SPHAGNUM AND EXTRACTS THEREOF

#8304
20230165914
2023-06-01

THERAPEUTIC AND DIAGNOSTIC USE OF MICROORGANISMS FOR COVID-19

#8305
20230165913
2023-06-01

MICROBIAL CONSORTIA

#8306
20230165907
2023-06-01

STEM CELL DRUG FOR TREATING DIABETES

#8307
20230165893
2023-06-01

TREATMENT OF VIRAL INFECTIONS

#8308
20230165886
2023-06-01

Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer

#8309
20230165885
2023-06-01

TREATMENT OF EYE DISORDERS WITH URIDINE PHOSPHATE DERIVATIVES

#8310
20230165884
2023-06-01

METHOD AND COMPOSITION FOR TREATING ALZHEIMERS

#8311
20230165877
2023-06-01

Administration and dosage of diaminophenothiazines

#8312
20230165875
2023-06-01

METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19

#8313
20230165874
2023-06-01

ANTICOAGULANT COMPOUNDS AND METHODS AND DEVICES FOR THEIR PULMONARY USE

#8314
20230165873
2023-06-01

Methods of Use for Single Molecule Compounds Providing Multi-Target Inhibition to Treat Covid 19

#8315
20230165871
2023-06-01

COMBINATION THERAPIES FOR INHIBITION OF POLO-LIKE KINASE 4

#8316
20230165868
2023-06-01

PARAXANTHINE-BASED COMPOSITIONS FOR ENHANCING MUSCLE FUNCTION, NITRIC OXIDE SIGNALING, AND/OR MUSCLE GLYCOGEN LEVELS

#8317
20230165861
2023-06-01

USE FOR PROTECTING OR MITIGATING RADIATION DAMAGE, AND FOR PREVENTING OR TREATING PULMONARY FIBROSIS

#8318
20230165860
2023-06-01

PYRIMIDINEDIONE COMPOUNDS

#8319
20230165859
2023-06-01

N-SUBSTITUTED INDOLE DERIVATIVES

#8320
20230165842
2023-06-01

NEW USES

#8321
20230165839
2023-06-01

MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE

#8322
20230165835
2023-06-01

METHODS OF TREATING ACUTE LUNG INJURY USING EBSELEN

#8323
20230165827
2023-06-01

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

#8324
20230165817
2023-06-01

DOPAMINERGIC MIMETICS

#8325
20230165813
2023-06-01

Histone acetyltransferase activators and compositions and uses thereof

#8326
20230165812
2023-06-01

NOCICEPTOR NEURONS CONTROL CANCER IMMUNOSURVEILLANCE

#8327
20230165811
2023-06-01

METHOD FOR TREATING SYMPTOMS OF VIRAL INFECTIONS

#8328
20230165807
2023-06-01

COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF

#8329
20230165803
2023-06-01

BIOPOLYMER-ENCAPSULATED GLYCOSYLTRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS

#8330
20230165788
2023-06-01

MULTI-DRUG FORMULATIONS FOR SUBCUTANEOUS BIODEGRADABLE RESERVOIR DEVICE

#8331
20230165248
2023-06-01

Antimicrobial Compositions and Related Methods of Use

#8332
20230160881
2023-05-25

HMGB1 RNA And Methods Therefor

#8333
20230159933
2023-05-25

COMPOSITIONS AND METHODS FOR SILENCING SCN9A EXPRESSION

#8334
20230159932
2023-05-25

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS ASSOCIATED WITH INFECTIOUS DISEASE

#8335
20230159923
2023-05-25

RIG-I Agonists and Methods of Using Same

#8336
20230159659
2023-05-25

INHIBITION OF CYSTATINS FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS

#8337
20230159652
2023-05-25

TRANSFERRIN RECEPTOR 1 TARGETING FOR CARCINOGENESIS PREVENTION

#8338
20230159647
2023-05-25

METHODS FOR TREATING ALLERGY AND ENHANCING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R INHIBITOR

#8339
20230159641
2023-05-25

ANTI-PD-L1 ANTIBODIES AND DIAGNOSTIC USES THEREOF

#8340
20230159640
2023-05-25

CARRIER-PD-L1 BINDING AGENT COMPOSITIONS FOR TREATING CANCERS

#8341
20230159639
2023-05-25

Anti-CD8 antibodies and uses thereof

#8342
20230159633
2023-05-25

Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody

#8343
20230159629
2023-05-25

COMPOSITIONS AND METHOD OF MODULATING GROWTH FACTOR FUNCTION

#8344
20230159627
2023-05-25

ANTI-C5A ANTIBODIES

#8345
20230159608
2023-05-25

MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND USES THEREOF

#8346
20230159607
2023-05-25

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUCOSITIS INDUCED BY RADIOTHERAPY, CHEMOTHERAPY, OR COMBINATION THEREOF, COMPRISING GLP-2 DERIVATIVES OR LONG-ACTING CONJUGATE OF SAME

#8347
20230159581
2023-05-25

NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS

#8348
20230159551
2023-05-25

DAPHNANE DITERPENOID RESISTANT TO PROSTATE CANCER AND PREPARATION METHOD THEREOF

#8349
20230159542
2023-05-25

RNA-BINDING PROTEIN MULTIMERIZATION INHIBITORS AND METHODS OF USE THEREOF

#8350
20230159534
2023-05-25

ADENOSINE RECEPTOR ANTAGONIST COMPOUNDS

#8351
20230159531
2023-05-25

HTT modulators for treating Huntington's disease

#8352
20230159514
2023-05-25

Compositions and methods for inhibiting kinases

#8353
20230159490
2023-05-25

TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES

#8354
20230159474
2023-05-25

Modulators of Mas-related G-protein receptor X4 and related products and methods

#8355
20230159470
2023-05-25

INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE, COMPOSITIONS AND USES THEREOF

#8356
20230159446
2023-05-25

Methods and Compositions for Targeting Tregs using CCR8 Inhibitors

#8357
20230159441
2023-05-25

ENZYME-CLEAVABLE METHADONE PRODRUGS AND METHODS OF USE THEREOF

#8358
20230159439
2023-05-25

ARYLAMIDES AND METHODS OF USE THEREOF

#8359
20230159438
2023-05-25

ARYLAMIDES AND METHODS OF USE THEREOF

#8360
20230159437
2023-05-25

Pantothenamide analogues

#8361
20230158259
2023-05-25

PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING MICROBIAL INFECTIONS

#8362
20230158148
2023-05-25

STIMULI RESPONSIVE BLOCK COPOLYMERS

#8363
20230158146
2023-05-25

HSP70 Inhibitors and Methods of Using Same

#8364
20230158139
2023-05-25

COMPOSITIONS AND METHODS FOR ENHANCING INNATE IMMUNITY IN A SUBJECT FOR THE TREATMENT OF OR REDUCING THE ONSET OF A HEALTH CONDITION

#8365
20230158132
2023-05-25

NOVEL TUMOR-SPECIFIC ANTIGENS FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AND USES THEREOF

#8366
20230158113
2023-05-25

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-BASED INFECTION TREATMENTS

#8367
20230158111
2023-05-25

MECHANICAL AND BIOCHEMICAL ACTIVATION AND CONTROL OF SKELETAL STEM CELLS FOR CARTILAGE REGENERATION

#8368
20230158109
2023-05-25

USE OF CD83 IN COMBINATION THERAPIES

#8369
20230158090
2023-05-25

COMPOSITIONS COMPRISING BACTERIAL STRAINS AND USE THEREOF FOR THE TREATMENT OF OCULAR DISEASES AND LESIONS

#8370
20230158085
2023-05-25

Inhibition of enteric infection through the modulation of microbiota

#8371
20230158083
2023-05-25

COMPOSITIONS COMPRISING BACTERIAL STRAINS

#8372
20230158078
2023-05-25

METHODS FOR TREATING ACUTE RESPIRATORY INFLAMMATORY CONDITIONS AND CYTOKINE STORM SYNDROME

#8373
20230158075
2023-05-25

METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY

#8374
20230158074
2023-05-25

B CELL IMMUNOMODULATORY THERAPY FOR ACUTE RESPIRATORY DISTRESS SYNDROME

#8375
20230158071
2023-05-25

TUMOR COMBINED IMMUNOTHERAPY

#8376
20230158057
2023-05-25

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN

#8377
20230158055
2023-05-25

METHODS AND REGIMENS FOR THE TREATMENT OF HEMATOLOGICAL CANCER

#8378
20230158043
2023-05-25

PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN

#8379
20230158042
2023-05-25

COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT

#8380
20230158039
2023-05-25

BROMODOMAIN INHIBITORS

#8381
20230158037
2023-05-25

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE

#8382
20230158032
2023-05-25

PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS

#8383
20230158031
2023-05-25

Treatment of Acute Respiratory Distress Syndrome and Other Disorders Involving Cytokine Storm Using BTK Inhibitors

#8384
20230158030
2023-05-25

METHODS AND COMPOSITION FOR TREATMENT OF COVID-19 ILLNESS REQUIRING HOSPITALIZATION

#8385
20230158029
2023-05-25

FOLATE COMPOSITIONS

#8386
20230158020
2023-05-25

Method for treating RNA viral infections, including COVID-19 (SARS-CoV-2)

#8387
20230158019
2023-05-25

Cancer therapy by degrading dual MEK signaling

#8388
20230158013
2023-05-25

Deuterated analogs of elacridar

#8389
20230158008
2023-05-25

METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS

#8390
20230158002
2023-05-25

Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid leukemias

#8391
20230158001
2023-05-25

PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND

#8392
20230158000
2023-05-25

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING VIRAL HEPATITIS AND THE USE THEREOF

#8393
20230157995
2023-05-25

Lasofoxifene treatment of breast cancer

#8394
20230157994
2023-05-25

NEW COMPOSITIONS AND METHODS OF TREATING COVID-19 DISEASE

#8395
20230157984
2023-05-25

Compositions comprising theanine, magnolia, and phellodendron

#8396
20230157976
2023-05-25

HEXYLAMINE SALTS AND METHODS OF USING HEXYLAMINE

#8397
20230157969
2023-05-25

POLYMERIC NANOPARTICLES PROVIDING NUCLEIC ACIDS ENCODING TNF-a

#8398
20230157963
2023-05-25

SOLID ORAL BEADS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME

#8399
20230157952
2023-05-25

METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL COMPOSITION OBTAINED THEREFROM

#8400
20230157951
2023-05-25

AEROSOL FORMULATION FOR COPD